Dr. Vokes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. MARYLAND
M/C 6092
Chicago, IL 60637Phone+1 773-702-9306Fax+1 773-702-4427- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1983 - 1986
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1982 - 1983
- Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1980 - 1982
- University of Bonn Faculty of MedicineClass of 1980
Certifications & Licensure
- IL State Medical License 1981 - 2026
- IN State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2009, 2012-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2012, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer Start of enrollment: 1996 Jun 01
- Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery Start of enrollment: 1998 Jul 01
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Start of enrollment: 1999 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Che...Jacobi B Hines, Robert B Cameron, Alessandra Esposito, Leeseul Kim, Luca Porcu, Antonio Nuccio, Giuseppe Viscardi, Roberto Ferrara, Giulia Veronesi, Patrick M Forde, J...> ;Journal of Thoracic Oncology. 2024 Mar 8
- Radiotherapy Enhances Metastasis Through Immune Suppression by inducing PD-L1 and MDSC in distal sites.Hou, Y., Yang, K., Wang, L., Wang, J., Huang, X., Piffko, A., Luo, S., Yu, X., Rao, E., Martinez, C., Bugno, J., Mack, M., Vokes, E., Pitroda, S., Chmura, S., Weichsel...> ;Clinical Cancer Research. 2024 Mar 1
- 1 citationsBintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomiz...Everett E Vokes, Francoise Mornex, Ahmet Sezer, Ying Cheng, Jian Fang, David Vicente Baz, Timucin Cil, Alex A Adjei, Myung-Ju Ahn, Fabrice Barlesi, Enriqueta Felip, Ed...> ;Journal of Thoracic Oncology. 2024 Feb 1
- Join now to see all
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Other
- Methods to overcome radiation resistance in head and neck cancerVokes EE, Brockstein BE, Yoo DS
http://www.uptodate.com/contents/methods-to-overcome-radiation-resistance-in-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-04-20 - Treatment of metastatic and recurrent head and neck cancerVokes EE, Brockstein BE
http://www.uptodate.com/contents/treatment-of-metastatic-and-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2013-03-05 - Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapyVokes EE, Brockstein BE
http://www.uptodate.com/contents/locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-appro
UpToDate, Wolters Kluwer Health - 2013-04-12
Press Mentions
- New Study Supports Saving More Lung Tissue in Lung Cancer SurgeriesMarch 24th, 2023
- Thomas Spiegel Appointed Vice President and Health System Chief Quality Officer at UChicago MedicineNovember 2nd, 2022
- ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
- Join now to see all
Grant Support
- Program 4 (Clinical And Experimental Therapeutics)National Cancer Institute2008–2012
- Tas:: 75 0850 ::Tas Recovery ACT - Actnow Clinical Trial 8418 UnderDivision Of Cancer Treatment2009
- Early Therapeutics Development With Phase II EmphasisDivision Of Cancer Treatment2009
- Early Therapeutics Development With Phase II EmphasisNational Cancer Institute2007
- Carcinogenesis And Novel Therapeutics In Oral CancerNational Institute Of Dental &Craniofacial Research1996–2001
- Planning And EvaluationNational Cancer Institute1996–2001
- Core--Protocol And Data Management OfficeNational Cancer Institute1996–2001
- Cooperative StudyNational Cancer Institute1994–2000
- Intravenous Administration Of 14C Losoxantrone (DUP941) For Solid TumorsNational Center For Research Resources1997
- Core--Biostatistical And Data Management FacilityNational Cancer Institute1992–1995
- Clinical InvestigationsNational Cancer Institute1992–1995
Professional Memberships
- Member
Hospital Affiliations
- University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: